Contravisory Investment Management Inc. lowered its position in shares of Agilent Technologies, Inc. (NYSE:A) by 10.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,721 shares of the medical research company’s stock after selling 328 shares during the quarter. Contravisory Investment Management Inc.’s holdings in Agilent Technologies were worth $322,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Newfound Research LLC acquired a new position in Agilent Technologies during the third quarter worth $32,000. NEXT Financial Group Inc purchased a new position in Agilent Technologies in the third quarter valued at approximately $34,000. NuWave Investment Management LLC raised its holdings in Agilent Technologies by 374.7% in the third quarter. NuWave Investment Management LLC now owns 451 shares of the medical research company’s stock valued at $46,000 after buying an additional 356 shares during the period. Liberty Wealth Management LLC raised its holdings in Agilent Technologies by 26.7% in the third quarter. Liberty Wealth Management LLC now owns 503 shares of the medical research company’s stock valued at $51,000 after buying an additional 106 shares during the period. Finally, Nachman Norwood & Parrott Inc purchased a new position in Agilent Technologies in the third quarter valued at approximately $52,000.
A has been the topic of several research reports. Morgan Stanley upgraded shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating in a report on Tuesday, November 3rd. UBS Group upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and raised their price target for the company from $103.00 to $132.00 in a report on Wednesday, November 25th. Zacks Investment Research upgraded shares of Agilent Technologies from a “sell” rating to a “hold” rating and set a $120.00 price target on the stock in a report on Wednesday, November 25th. Sanford C. Bernstein upgraded shares of Agilent Technologies from a “market perform” rating to an “outperform” rating in a research note on Thursday, December 3rd. Finally, KeyCorp began coverage on shares of Agilent Technologies in a research note on Monday, November 9th. They set an “overweight” rating and a $130.00 price objective on the stock. Twelve equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Agilent Technologies has a consensus rating of “Buy” and an average target price of $89.74.
Shares of Agilent Technologies stock opened at $126.98 on Thursday. The company has a current ratio of 2.33, a quick ratio of 1.84 and a debt-to-equity ratio of 0.47. The company’s 50-day moving average price is $118.54 and its two-hundred day moving average price is $104.44. Agilent Technologies, Inc. has a 52 week low of $61.13 and a 52 week high of $129.34. The stock has a market cap of $38.96 billion, a PE ratio of 55.21, a price-to-earnings-growth ratio of 3.85 and a beta of 1.04.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Sunday, November 22nd. The medical research company reported $0.98 EPS for the quarter, topping the consensus estimate of $0.93 by $0.05. The firm had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.40 billion. Agilent Technologies had a net margin of 13.47% and a return on equity of 21.02%. During the same period in the previous year, the business earned $0.89 earnings per share. On average, equities analysts predict that Agilent Technologies, Inc. will post 3.67 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 27th. Investors of record on Tuesday, January 5th will be paid a $0.194 dividend. The ex-dividend date of this dividend is Monday, January 4th. This represents a $0.78 dividend on an annualized basis and a yield of 0.61%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.18. Agilent Technologies’s dividend payout ratio (DPR) is currently 23.78%.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Featured Article: Most Volatile Stocks – What Investors Need to Know to Maximize ROI
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.